From October 1, 2023 to December 31, 2023, the company has repurchased 0 shares, representing 0% for CNY 0 million. With this, the company has completed the repurchase of 5,958,154 shares, representing 0.75% for CNY 122.88 million under the buyback announced on July 17, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
27.49 CNY | -0.29% | -0.33% | +23.66% |
May. 24 | Jafron Biomedical Co.,Ltd. Announces Final Dividend on A Shares for 2023, Payable on 31 May 2024 | CI |
Apr. 26 | Jafron Biomedical Co.,Ltd. Proposes Final Dividend for the Year 2023 | CI |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+23.66% | 2.94B | |
-1.14% | 187B | |
+1.51% | 110B | |
-1.65% | 69.54B | |
+13.27% | 46.37B | |
-6.29% | 46.05B | |
+7.97% | 42.54B | |
+18.05% | 30.72B | |
+17.70% | 25.62B | |
-7.37% | 23.32B |
- Stock Market
- Equities
- 300529 Stock
- News Jafron Biomedical Co.,Ltd.
- Tranche Update on Jafron Biomedical Co.,Ltd.'s Equity Buyback Plan announced on July 17, 2023.